A New Postpartum Depression Drug Could Lead to a Revolution in Treating Women’s Mental Health Issues

About one in seven women who give birth in the U.S. experience postpartum depression—a condition that can leave them exhausted, make it difficult for them to bond with their babies, and even generate thoughts of suicide. Left untreated, the condition can become chronic and interfere with the development of suffering mothers’ babies. It also takes … Read more

The FDA’s New Guillain-Barre Warning For the J&J Vaccine Reflects a Small Increased Risk of the Illness

0000000000000 As millions of people get vaccinated against COVID-19, the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are closely monitoring reports of side effects and adverse events among people getting immunized. On July 12, the FDA added a warning about the risk of Guillain-Barre to the single-dose … Read more

Contraceptive Access May Not Be as Life-Changing for the World’s Poorest Women as Previously Thought, According to a New Study

At the Generation Equality Forum in Paris in early July, the U.N. attracted political and business leaders from across the globe to talk about gender equality, and also invited them to put their moneys where their mouths were. Among the Forum’s seven key platforms were a push for more economic justice for women—meaning equal access … Read more